A comprehensive view of Alzheimer's Assn. International Conference. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Alzheimer’s Drug Discovery Foundation optimistic about Eli Lilly's positive data on anti-amyloid therapy donanemab, presented at the Alzheimer’s Assn. International Conference; Phase 3 research emphasized need for biomarker-powered clinical trials
Published:
July 21, 2023
by Indian Pharma Industry: Policies
|
Lilly announces webcast to provide Alzheimer's Disease update at Alzheimer's Association International Conference on Monday, July 17, 2023 beginning at 1:30 p.m. ET
Published:
July 11, 2023
by Eli Lilly & Co.
|
Ask us about our Health Care Sector market view